1. Home
  2. AG vs KYMR Comparison

AG vs KYMR Comparison

Compare AG & KYMR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo First Majestic Silver Corp. (Canada)

AG

First Majestic Silver Corp. (Canada)

HOLD

Current Price

$16.96

Market Cap

8.4B

ML Signal

HOLD

Logo Kymera Therapeutics Inc.

KYMR

Kymera Therapeutics Inc.

HOLD

Current Price

$114.74

Market Cap

9.6B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
AG
KYMR
Founded
1979
2015
Country
Canada
United States
Employees
N/A
N/A
Industry
Precious Metals
Medicinal Chemicals and Botanical Products
Sector
Basic Materials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
8.4B
9.6B
IPO Year
2004
2020

Fundamental Metrics

Financial Performance
Metric
AG
KYMR
Price
$16.96
$114.74
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
3
26
Target Price
$21.92
$107.72
AVG Volume (30 Days)
11.7M
1.1M
Earning Date
05-12-2026
04-30-2026
Dividend Yield
0.12%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$39,211,000.00
Revenue This Year
$24.41
$10.61
Revenue Next Year
$10.68
$8.17
P/E Ratio
$143.01
N/A
Revenue Growth
N/A
N/A
52 Week Low
$7.74
$36.88
52 Week High
$32.00
$130.05

Technical Indicators

Market Signals
Indicator
AG
KYMR
Relative Strength Index (RSI) 43.01 74.43
Support Level $15.58 $72.91
Resistance Level $17.37 N/A
Average True Range (ATR) 0.91 7.53
MACD -0.00 3.09
Stochastic Oscillator 32.23 71.86

Price Performance

Historical Comparison
AG
KYMR

About AG First Majestic Silver Corp. (Canada)

First Majestic Silver Corp is in the business of production, development, exploration, and acquisition of mineral properties with a focus on silver and gold production in North America. The company owns four producing mines in Mexico, consisting of the Santa Elena Silver/Gold Mine, the San Dimas Silver/Gold Mine, the Los Gatos Silver Mine, and the La Encantada Silver Mine. It also owns the Jerritt Canyon Gold Mine in Nevada, USA. Additionally, the firm holds interests in the San Martin Silver Mine and the Del Toro Silver Mine, and several exploration-stage projects. The majority of the company's revenues are from the sale of precious metals contained in dore and concentrate form. It generates maximum revenue from the sale of silver, followed by gold, zinc, copper, and other metals.

About KYMR Kymera Therapeutics Inc.

Kymera Therapeutics Inc is a clinical-stage biopharmaceutical company dedicated to reinventing the treatment of human disease through the development of differentiated medicines that address health problems and meaningfully improve patients' lives. It is committed to novel technologies to address targets that have known disease-causing biology, but which have not been drugged, or have been inadequately drugged, often based on limitations of existing technologies. Its approach is intended to discover and develop a new generation of medicines in a disease-agnostic manner. Its product pipelines are STAT6, and IRAK4.

Share on Social Networks: